The bill establishes new regulations regarding cost-sharing requirements for insulin and diabetes supplies in Florida. It creates a new section, 627.42398, in the Florida Statutes, which defines "cost-sharing requirement" as any out-of-pocket expense such as deductibles, coinsurance, or copayments. The bill mandates that health insurance policies issued or renewed on or after January 1, 2027, cannot impose a cost-sharing requirement exceeding $35 for a 30-day supply of insulin and $100 for a 30-day supply of diabetes supplies, which includes various necessary items for managing diabetes.

The legislation aims to ensure that individuals with diabetes have affordable access to essential medications and supplies. By capping the out-of-pocket costs for these items, the bill seeks to alleviate the financial burden on patients and promote better health outcomes. The act is set to take effect on July 1, 2026.